Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Blockmans

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Arthritis and Rheumatism|December 14, 2004
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis TrialFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Arthritis and Rheumatism|September 5, 2002
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Nature Reviews. Rheumatology|September 15, 2017
Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitisXavier Bossuyt, Jan-Willem Cohen Tervaert, Yoshihiro Arimura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2015
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapyChristian Pagnoux, Thomas Quéméneur, Jacques Ninet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 20, 2020
Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control StudyLaure Delaval, Maxime Samson, Flora Schein, et al.
Seminars in Arthritis and Rheumatism|May 10, 2022
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient dataAndrea K Hemmig, Daniele Gozzoli, Laura Werlen, et al.
Rheumatology (Oxford, England)|August 29, 2020
Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven casesCécile-Audrey Durel, Renato A Sinico, Vitor Teixeira, et al.
Annals of the Rheumatic Diseases|August 7, 2023
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 updateChristian Dejaco, Sofia Ramiro, Milena Bond, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
International Consensus on ANCA Testing in Eosinophilic Granulomatosis with PolyangiitisSergey Moiseev, Xavier Bossuyt, Yoshihiro Arimura, et al.
Annals of the Rheumatic Diseases|March 17, 2023
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateBernhard Hellmich, Beatriz Sanchez-Alamo, Jan H Schirmer, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Arthritis and Rheumatism|December 14, 2004
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis TrialFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Arthritis and Rheumatism|September 5, 2002
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Nature Reviews. Rheumatology|September 15, 2017
Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitisXavier Bossuyt, Jan-Willem Cohen Tervaert, Yoshihiro Arimura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2015
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapyChristian Pagnoux, Thomas Quéméneur, Jacques Ninet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 20, 2020
Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control StudyLaure Delaval, Maxime Samson, Flora Schein, et al.
Seminars in Arthritis and Rheumatism|May 10, 2022
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient dataAndrea K Hemmig, Daniele Gozzoli, Laura Werlen, et al.
Rheumatology (Oxford, England)|August 29, 2020
Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven casesCécile-Audrey Durel, Renato A Sinico, Vitor Teixeira, et al.
Annals of the Rheumatic Diseases|August 7, 2023
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 updateChristian Dejaco, Sofia Ramiro, Milena Bond, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
International Consensus on ANCA Testing in Eosinophilic Granulomatosis with PolyangiitisSergey Moiseev, Xavier Bossuyt, Yoshihiro Arimura, et al.
Annals of the Rheumatic Diseases|March 17, 2023
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateBernhard Hellmich, Beatriz Sanchez-Alamo, Jan H Schirmer, et al.
Pageof 15